Abstract: A system containing a reactor vessel including zero valent iron media, a source of a conditioning additive, a source of a reaction additive, and a process control subsystem is disclosed. A method for reducing a concentration of one or more contaminants in contaminated water including contacting zero valent iron media with a conditioning additive, contacting contaminated water with conditioned zero valent iron media, and introducing a reaction additive is also disclosed. The conditioning additive and reaction additive may each contain an aluminum salt.

Abstract: Hydrogel-based sorbents and methods for their use in collecting, concentrating, and removing environmental per- and poly-fluoroalkyl substances. In one aspect, the invention provides hydrogel-based sorbents that are effective for collecting, concentrating, and removing PFASs from an environment in which the sorbent is placed; an environment in which the sorbent is in contact with (e.g., liquid communication).

Abstract: Methods and reactors for electrochemically expanding a parent material and expanded parent materials are described. Current methods of expanding parent materials incompletely-expand parent material, requiring expensive and time-consuming separation of expanded parent material from unexpanded parent materials. This problem is addressed by the methods and reactor for electrochemically expanding a parent material described herein, which during operation maintain electrical connectivity between the parent material and an electrical power source. The resulting materials described herein have a greater proportion of expanded parent material relative to unexpanded parent material compared to those made according to others methods.

Abstract: Disclosed herein are antisense oligonucleotides that are capable of inducing expression of ubiquitin-protein ligase E3A (UBE3A) from the paternal allele in animal or human neurons. The oligonucleotides target the suppressor of the UBE3A paternal allele by hybridization to SNHG14 long non-coding RNA at the 5?-end of UBE3A-AS, which is downstream of SNORD115-45 snoRNA. Also disclosed are pharmaceutical compositions and methods for treatment of Angelman syndrome.

Abstract: In an embodiment, the present disclosure pertains to a cavitation generation device that includes a dactyl plunger rotatable about an axis between an open position and a closed position and a propus socket having a channel. The propus socket is rigidly mounted below the dactyl plunger, and the dactyl plunger is received into the propus socket when the dactyl plunger is in the closed position. The cavitation generation device can also include a torsion spring that biases the dactyl plunger into contact with the propus socket. In another embodiment, the present disclosure pertains to a method of inducing a cavitation including biasing a dactyl plunger via a torsion spring, and rotating the dactyl plunger, by action of the torsion spring, into a propus socket. The propus socket includes a nozzle-shaped channel. The method further includes ejecting a socket cavity volume through the nozzle-shaped channel thereby inducing a cavitation event.

Abstract: A pyrolysis and gasification system produce a synthesis gas and bio-char from a biomass feedstock. The system includes a feed hopper that has a flow measurement device. The system also includes a reactor that is operable in a gasification mode or a pyrolysis mode. The reactor is configured to receive the biomass feedstock from the feed hopper. The reactor is operable to provide heat to the biomass feedstock from the feed hopper to produce the synthesis gas and bio-char. The system also includes a cyclone assembly. The produced synthesis gas including the bio-char is fed to the cyclone assembly. The cyclone assembly removes a portion of the bio-char from the synthesis gas.

Abstract: A system for evaluating an ability of a blood sample to coagulate, clot, and/or occlude includes a microfluidic device including a body and a tortuous microchannel formed in the body, wherein the tortuous microchannel includes a plurality of alternating curves and has a tortuosity index (TI) of at least 2.0, and a pump fluidically configured to fluidically connect to the tortuous microchannel of the microfluidic device and to induce a blood flow through the tortuous microchannel at at least one of a constant pressure and a constant flowrate.

Abstract: A system for reducing a microbial and/or viral load on equipment using ozone includes a container including having an open configuration to provide access to an interior of the container and a closed configuration to seal the interior from an environment external the container, and wherein the interior includes a receptive region to receive the equipment, a circulation fan positioned in the interior of the container, and one or more ozone generators positioned in the interior of the container and configured to generate ozone upon activation, wherein the circulation fan is configured to provide an airflow including ozone generated by the one or more ozone generators and directed along a flowpath extending into the receptive region of the interior of the container.

Abstract: A system for treating an aneurysm in a blood vessel or vein, wherein the aneurysm has a dome, an interior, and a neck. The system includes a shape memory polymer foam in the interior of the aneurysm between the dome and the neck. The shape memory polymer foam has pores that include a first multiplicity of pores having a first pore size and a second multiplicity of pores having a second pore size. The second pore size is larger than said first pore size. The first multiplicity of pores are located in the neck of the aneurysm. The second multiplicity of pores are located in the dome of the aneurysm.

Abstract: Functionalized pyrano[2,3-d]pyrimidin-7-one derivatives, methods for making the derivatives, and methods of using the derivatives as protein kinase inhibitors.

Abstract: Processes and systems for electrochemical exfoliation that use a compression reactor and, more particularly, to processes and systems for electrochemical exfoliation of planar parent materials, such as graphite. A reactor for electrochemical exfoliation may include a container configured to hold an electrolyte solution. The reactor may further include a porous chamber, wherein the porous chamber is configured to hold a parent material in fluid communication with the electrolyte solution. The reactor may further include a pressure source positioned to apply a pressure along a length of the porous chamber to thereby compress the parent material in the porous chamber. The reactor may further include a first counter electrode. The reactor may further include a working electrode. The reactor may further include an electrical power source in electrical communication with the first counter electrode and the working electrode.

Abstract: Exfoliated nanoplatelets functionalized with a non-polar moiety, such as an ethylene or propylene derived polymer, are useful for forming composites, films, and polymer blends.

Abstract: A lateral superjunction includes a substrate layer, a selective epitaxy layer deposited on the substrate layer, a trench formed into the selective epitaxy layer to expose a portion of the substrate layer, a first layer of semiconductor deposited in the trench, a second layer of semiconductor deposited adjacent to the first layer, and a first end layer of semiconductor deposited adjacent to the first layer of semiconductor and a second end layer of semiconductor deposited adjacent to the second layer of semiconductor.

Abstract: An embodiment of the invention is a shape memory polymer (SMP) foam designed to recover its original shape through exposure to a solvent. Thermo-responsive SMPs are polymers designed to maintain a programmed secondary shape until heated above their transition temperature, upon which the polymer recovers its original, or primary, shape. The thermo-responsive SMP foam is programmed to its secondary shape prior to use, typically compression of the foam to a small volume, and remains in this programmed shape until exposed to a selected solvent such as dimethyl sulfoxide or ethyl alcohol. Upon exposure to the solvent, the transition temperature of the SMP foam decreases below the temperature of the environment and the SMP foam actuates to its primary shape. The SMP foam is tailored to actuate upon exposure to specific solvents while minimizing or preventing actuation when exposed to water or other solvents.

Abstract: The invention relates to methods for treating cancers by targeting the elimination of selective activated immune cell populations in combination with checkpoint inhibitors. The cells may be targeted, for instance, using CLIP inhibitors and or MHC class II inducers.

Abstract: A hover-capable aircraft includes a body including a tubular strut, a first rotor assembly rotatably coupled to the body and positioned about the strut, wherein the first rotor assembly includes a first plurality of circumferentially-spaced blades, a first actuation assembly including a first plurality of electronically controlled actuators coupled to a first swashplate and configured to control the movement of the first swashplate relative to the body, and a control system coupled to the body and configured to control the first plurality of actuators, wherein the control system includes a cable extending through a passage formed in the tubular strut and in signal communication with the first plurality of actuators.

Abstract: Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, one or more substituted quinols, or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, or a combination thereof in an amount and formulation sufficient to sensitize the parasite to the drug, treating infection of a patient by a parasite with a drug, or to prevent symptomatic infection of a patient by a parasite with a drug.

Abstract: Methods and systems for reducing the concentration of selenium species in water, particularly water containing recalcitrant selenium species. In the methods and systems, water containing one or more selenium species is treated with permanganate to provide permanganate-treated water, which is then contacted with a zero-valent iron treatment system comprising (a) a reactive solid comprising zero-valent iron and one or more iron oxide minerals in contact therewith and (b) ferrous iron.

Abstract: Activated iron media and methods for generating and using the activated iron media. The method involves aqueous suspension comprising a zero-valent iron, ferrous iron, and an iron oxide to provide a settled solid and re-suspending the settled solid to provide an aqueous suspension containing an activated iron media.

Abstract: A microfluidic device includes a microfluidic channel formed in the microfluidic device and defined by a floor and a ceiling positioned vertically above the floor, wherein the microfluidic channel includes at least one fluid inlet configured to receive a fluid flow and at least one fluid outlet, and wherein at least one of the ceiling and the floor of the microfluidic channel is sloped relative to a horizontal plane.